Bridgebio Pharma Inc (BBIO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BBIO Annual Balance Sheets →
The balance sheet data below highlights changes in Bridgebio Pharma Inc's financial position over recent quarters.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/BBIO/balance-sheets
https://api.csimarket.com/api/v1/companies/BBIO/fundamentals
https://api.csimarket.com/api/v1/companies/BBIO/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent1,533.36
Restricted Cash0.55
Available-for-sale Securities, Debt Securities, Current MA5.49
Cash & Short-term Investments1,538.00
Accounts receivable375.09
Inventories59.72
Prepaid Expense And Other Assets Current70.94
Total Current Assets2,044.61
Equipment/Property/Plant Net5.04
Intangible Assets25.92
Long-term investments47.78
Other Assets, Noncurrent38.43
Operating Lease Right Of Use Asset17.23
Total Assets2,161.79
Liabilities
Accounts Payable, Current AC88.26
Employee-related Liabilities, Current AC66.69
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current822.29
Total Current Liabilities977.24
Long-term debt2,630.05
Total Long-term Debt2,630.05
Other liabilities, Noncurrent208.00
Operating Lease Liability Current4.44
Convertible Senior Notes-
Operating Lease Liability Noncurrent14.22
Total Liabilities3,815.29
Stockholders' Equity
Temporary Equity Carrying Amount Net Including Portion Attributable To Noncontrolling Interests-0.95
Common Stock Value0.21
Additional Paid In Capital Common Stock2,170.01
Retained Earnings / Accumulated Deficit-4,194.16
Accumulated Other Comprehensive Income-0.10
Other Equity-0.10
Common Stockholder's Equity-1,660.98
Non-controlling interests & other-1.36
Total Stockholder's Equity-1,662.34
Liabilities & Stockholder's Equity2,161.79
4 historic quarters locked

Sign in to unlock the full Bridgebio Pharma Inc balance sheet history.

About Bridgebio Pharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001743881-26-000034

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI